• 2
  • html slider
  • 4
1 22 33 44
css image gallery by WOWSlider.com v8.8
Conference Topics
5 September 2020 (Saturday)
08:30-09:10 Keynote speech: Vaccines for cancer prevention
09:10-10:30 Plenary Session
1. Emerging issues of vaccination
2. Dengue Vaccines: How Do We Get To The Finish Line?
10:50-12:35 Session 1: Basic Vaccinology
1. Basic concepts of vaccination
2. Safety issues of vaccination
3. Vaccine hesitancy
14:00-15:30 Session 2A: Rotavirus vaccines Session 2B: Hepatitis and Haemophilus influenzae type b vaccine
1. Long term evidences on homotypic protection of rotavirus vaccine. 1. Use of combination vaccines containing Haemophilus influenzae b vaccine
2. Heterotypic protection of rotavirus vaccine 2. Preventive strategies against hepatitis A and hepatitis E
3. Effectiveness and safety of rotavirus vaccination in the real world  3. Preventive strategies against hepatitis B and hepatitis C
15:50-17:20 Session 3A: Pneumococcal vaccine Session 3B: Measles, mumps, rubella, and polio vaccines
1. Clinical impact of 10-valent pneumococcal conjugate vaccine 1. Efficacy, effectiveness and impact of MMR vaccine
2. Clinical impact of 13-valent pneumococcal conjugate vaccine 2. Global resurgence and control strategies of measles and rubella 
3. Pneumococcal vaccination in Asia  3. Polio eradication and endgame strategy
4. Why multivalent pneumococcal vaccine is needed?  
6 September 2020 (Sunday)
08:00-09:30 Session 4A: Human papillomavirus vaccine Session 4B: BCG and Pertussis vaccine
1. Preventing HPV infection by using 2-valent HPV vaccine 1. Updates on the development of tuberculosis vaccines
2. 4-valent and 9-valent HPV Vaccines in the real world 2. Pertussis: a neglected disease in Asian countries
3. Use of HPV vaccine in the real world: expected and unexpected 3. Effectiveness of different acellular pertussis vaccines 
09:50-11:20 Session 5A: Varicella/Zoster vaccine Session 5B: Influenza vaccine
1. Clinical application off varicella vaccine 1. Influenza vaccination program in Asia-Pacific region
2. Varicella vaccination in NIP program: one dose or two doses? 2. High-dose Influenza vaccine for the elderly
3. Importance of adult vaccine &  Patient engagement of herpes zoster vaccine (TBC) 3. Adjuvanted influenza vaccine for the elderly
4. Inactivated herpes zoster vaccine  
11:20-12:50 Session 6A: Asian Strategic Alliance for Pneumococcal Disease Prevention Symposium  Session 6B: New vaccines and vaccine in pipeline 
1. Epidemiology and preventive strategies of pneumococcal diseases in Asia 1. Current development of enterovirus 71 vaccines 
2. Barriers to the implementation of pneumococcal conjugate vaccine in children 2. Enterovirus 71 vaccine in Taiwan
3. Emerging issues after pneumococcal conjugate vaccination programs 3. Dengue fever vaccine
4. Use of pneumococcal vaccines in the elderly 4. An update on Zika virus vaccines
13:50-15:20 Session 7A: Japanese encephalitis vaccine Session 7B: New vaccine technologies
1. Epidemiology and preventive strategies of JE in Asia 1. New development of bacterial vaccines
2. Cell-based inactivated JE vaccine 2. New vaccine strategies for respiratory diseases: RSV; TB; COPD-
3. Live attenuated chimeric JE vaccine 3. Modern technology for vaccine development 

Copyright © 2019, MasterClass in Vaccinology, 2020, All Rights Reserved.